19 Nov 2024 ATB Therapeutics Raises €54 Million Series A Financing to Propel Innovative Antibody Payload Technology into Clinical Development Member news
15 Nov 2024 FDA authorizes the first AI-driven MRI solution for safer Alzheimer’s treatment Member news
09 Nov 2024 Therapeutic potential of a novel mixture of mRNA in nanoparticles overcomes tumor progression Member news
06 Nov 2024 Galapagos to Present Results of Pioneering Innovation in Cancer Cell Therapy at ASH 2024 Member news
01 Nov 2024 reMYND announces positive Phase 2a clinical trial results for treatment of mild-to-moderate Alzheimer’s disease Member news
29 Oct 2024 Rejuvenate Biomed, the NIHR Leicester BRC, and Wellcome Leap partner for Phase 2 Study in COPD-related sarcopenia Member news
More info? Ellen Telleir Communication Coordinator linkedin.com/in/ellentelleir/ +32 9 241 80 41 ellen.telleir@flanders.bio Contact us
